Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell College Union #pharma #engineering

Posted On May 19 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …


Pharmaceutical Consultant Pharmacy Pharmaceutical Consultant Pharmaceutical Consultant Firm #pharma #logo

Posted On May 18 2017 by

#pharma consultant # Maximize the effectiveness of your sales force? Coach product management? Slow the erosion of patent expired products? Reduce the cost of company meetings? Position your products for the highest rates of return? Establish a co-promotion arrangement? Find hidden revenue opportunities? Confirm what your product positioning strategy is? Create marketing programs that have documented returns? We are a small boutique-consulting firm with access to a variety of experts in the industry. We can offer your organization a wealth of experience and knowledge for a fraction of the cost of the major consulting firms. In today’s highly complex pharmaceutical …


Saneca-owned generics firm Suir Pharma will sack 130 staff says liquidator #pharma #kava

Posted On May 18 2017 by

#outsourcing pharma # Saneca-owned generics firm Suir Pharma will sack 130 staff says liquidator By Gareth MacDonald+ Gareth MACDONALD 18-May-2016 2016-05-18T00:00:00Z Last updated on 18-May-2016 at 17:00 GMT 2016-05-18T17:00:29Z Suir Pharma is set to close or be sold with the loss of 130 jobs less than a year after it was acquired by Slovakian API manufacturer Saneca Pharmaceuticals. The Irish High Court appointed Michael McAteer from Grant Thornton as Suir’s liquidator on Tuesday, tasking him with either finding a buyer for the generic drug manufacturer or with helping it wind up its operations. A Grant Thornton spokesman told us the …


MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm – CenterWatch News Online #astellas #pharma #inc

Posted On May 3 2017 by

#mds pharma services #


OxyContin s Deception Costs Firm $634M – CBS News #pharmaceutical #manufacturing #industry

Posted On Apr 26 2017 by

#perdue pharma # OxyContin’s Deception Costs Firm $634M Two days after agreeing to pay states nearly $20 million for falsely marketing OxyContin, the drug’s maker, Perdue Pharma, and three current and former executives plead guilty to federal charges. The Stamford, Conn.-based maker of the powerful painkiller, and three of its current and former executives, pleaded guilty Thursday to misleading the public about OxyContin’s risk of addiction, a federal prosecutor and the company said. Purdue Pharma L.P. its president, top lawyer and former chief medical officer will pay $634.5 million in fines for claiming the drug was less addictive and less …


Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell College Union #teva #pharma #jobs

Posted On Apr 23 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #cmc #pharma

Posted On Apr 23 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


Market Research Reports, Industry Research Firm, Consulting Services #pharmaceutical #industry #research

Posted On Apr 21 2017 by

#market research reports # OUR MARKET RESEARCH SERVICES Syndicated Research TMR’s syndicated research reports offer ready, data-driven answers to several industry-level questions. Our syndicated reports assess the impact of market variations across verticals such as pharmaceuticals, chemicals, technology, media, food, energy, mining, consumer goods, and electronics. From venture capitalists to investors to academic institutions, TMR’s syndicated market reports provide a highly detailed yet integrated solution to clients worldwide. Custom Research TMR’s customized research services address clients’ problem statements in markets and sectors where ready-made solutions aren’t enough. Our customized research combines surveys, interviews, primary and secondary research, and competitive intelligence …


MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm – CenterWatch News Online #pharmaceutical #contract #manufacturing

Posted On Apr 14 2017 by

#mds pharma services #


Pharmaceutical Consultant Pharmacy Pharmaceutical Consultant Pharmaceutical Consultant Firm #sankyo #pharma

Posted On Apr 13 2017 by

#pharma consultant # Maximize the effectiveness of your sales force? Coach product management? Slow the erosion of patent expired products? Reduce the cost of company meetings? Position your products for the highest rates of return? Establish a co-promotion arrangement? Find hidden revenue opportunities? Confirm what your product positioning strategy is? Create marketing programs that have documented returns? We are a small boutique-consulting firm with access to a variety of experts in the industry. We can offer your organization a wealth of experience and knowledge for a fraction of the cost of the major consulting firms. In today’s highly complex pharmaceutical …